1. Bell A (1981) Metabolic studies with fazadinium dibromide. Ph.D. thesis (Council for National Academic Award)
2. Blogg CE, Simpson BR, Martin LE, Bell JA (1973) Metabolism of 3H-AH 8165 in man. Br J Anaesth 45:1233–1234
3. Bolger L, Brittain RT, Jack D, Jackson MR, Martin LE, Mills J, Poynter D, Tyers MB (1972) Short lasting competitive neuromuscular blocking activity in a series of azobisarylimidazo-(l,2-a)-pyridinium dihalides. Nature 238:354–355
4. Bouyard P, Mesdjian E, Balansard P, Gastant JA, Jadot G (1973) Pharmacologie du dibromure de l-l’azo’bis-3-methyl-2-phenyl-1H-imidazo-(1,2-a)pyridinium, AH 8165, nouveau curarimimetic. Ann Anaesthiol Fr XIV:397–403
5. Brittain RT, Tyers MB (1972) AH 8165: a new short-acting competitive neuromuscular blocking drug. Br J Pharmacol 45:158–159P